Edition:
United States

Curis Inc (CRIS.OQ)

CRIS.OQ on NASDAQ Stock Exchange Global Market

0.55USD
16 Feb 2018
Change (% chg)

$-0.01 (-1.37%)
Prev Close
$0.55
Open
$0.56
Day's High
$0.57
Day's Low
$0.54
Volume
119,469
Avg. Vol
297,038
52-wk High
$3.22
52-wk Low
$0.49

Chart for

About

Curis, Inc. is a biotechnology company seeking to develop and commercialize drug candidates for the treatment of cancers. The Company's drug candidate is CUDC-907, an orally-available, small molecule inhibitor of histone deacetylase (HDAC) and phosphatidylinositol-3-kinase (PI3K) enzymes. CUDC-907 is an oral, dual inhibitor of... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $89.54
Shares Outstanding(Mil.): 163.98
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 178.11 17.27
EPS (TTM): -- -- --
ROI: -- -1.15 35.43
ROE: -- -20.84 17.10

BRIEF-Curis announces pricing of public offering of common stock

* Curis Inc - pricing of an underwritten public offering of 20 million shares of its common stock​ Source text for Eikon: Further company coverage:

Sep 14 2017

BRIEF-Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

* Curis and Aurigene announce CA-170 program update following data presented at ESMO 2017

Sep 11 2017

Earnings vs. Estimates